--- schema_version: "secwatch.filing_event.v1" accession: "0001564590-23-000429" form_type: "8-K" ticker: "VTAK" cik: "0001716621" company_name: "Catheter Precision, Inc." filed_at: "2023-01-13T23:59:59+00:00" generated_at: "2026-06-20T15:22:21.300834+00:00" event_type: "m_and_a" sentiment: "neutral" materiality_score: 0.85 calibrated_materiality_score: 0.85 confidence: "high" source: SEC EDGAR --- # Ra Medical acquires Catheter Precision; shifts focus to electrophysiology products ## Summary - Acquired Catheter for ~14,650 Series X Preferred shares; Catheter debt converted at $3.20 per 1/1000th share. - Warrants repriced to $4 from $14–$526; Armistice exercises ~332K warrants for $1.3M gross proceeds. - Private placement of $8M with Armistice via Class A/B units, subject to stockholder approval. - Board changes: Richard Mejia, Joan Stafslien resigned; David Jenkins appointed Executive Chairman, James Caruso appointed. - Post-merger company will not use legacy assets; focus shifts to Catheter's VIVO, Amigo, and vessel closure device. ## SEC filing metadata - accession: 0001564590-23-000429 - form_type: 8-K - ticker: VTAK - cik: 0001716621 - company_name: Catheter Precision, Inc. - filed_at: 2023-01-13T23:59:59+00:00 - event_type: m_and_a - sentiment: neutral - materiality_score: 0.85 - calibrated_materiality_score: 0.85 - confidence: high - sec_items: 1.01, 2.01, 3.02, 3.03, 5.02, 5.03, 8.01, 9.01 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/rmed-8k_20230109.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001564590-23-000429 - JSON: https://secwatch.observer/filing/0001564590-23-000429.json - Plain text: https://secwatch.observer/filing/0001564590-23-000429.txt ## Key facts - Executive change James Caruso was appointed as Director at Catheter Precision, Inc.. - Action: appointed - Role: Director source text: Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - Executive change Richard Mejia, Jr. resigned as Director at Catheter Precision, Inc.. - Action: resigned - Role: Director source text: Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - Executive change Joan Stafslien resigned as Director at Catheter Precision, Inc.. - Action: resigned - Role: Director source text: Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - Executive change David Jenkins was appointed as Executive Chairperson of the Board at Catheter Precision, Inc.. - Action: appointed - Role: Executive Chairperson of the Board source text: Pursuant to the terms of the Merger Agreement, as of immediately following the First Effective Time, Richard Mejia, Jr. and Joan Stafslien resigned from the Board of Directors and any committees of the Board of Directors to which they belonged and David Jenkins (Class II) and James Caruso (Class III) were appointed to the Board of Directors, with Mr. Jenkins becoming Executive Chairperson of the Board evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - Governance Changes Catheter Precision, Inc.: Filed Certificate of Designation for Series X Convertible Preferred Stock establishing rights, preferences, and limitations (effective 2023-01-09). - Change: charter amendment - Effective: 2023-01-09 source text: On January 9, 2023, the Company filed a Certificate of Designation of Preferences, Rights and Limitations of the Series X Convertible Preferred Stock with the Secretary of State of the State of Delaware (the “Series X Certificate of Designation”) evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - M&A Transactions Catheter Precision, Inc. completed an acquisition involving Catheter Precision, Inc. (closed 2023-01-09). - Action: acquisition - Counterparty: Catheter Precision, Inc. - Closing: 2023-01-09 source text: On January 9, 2023, Ra Medical Systems, Inc., a Delaware corporation (the “Company” or “Ra Medical”), completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation (“Catheter”), pursuant to an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”) evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm - Material Agreements Catheter Precision, Inc. entered into Amended and Restated Agreement and Plan of Merger with Catheter Precision, Inc., Rapid Merger Sub 1, Inc., and Rapid Merger Sub 2, LLC (effective 2023-01-09). - Action: entry - Agreement: merger - Counterparty: Catheter Precision, Inc., Rapid Merger Sub 1, Inc., and Rapid Merger Sub 2, LLC - Effective: 2023-01-09 source text: On January 9, 2023, Ra Medical Systems, Inc., a Delaware corporation (the “Company” or “Ra Medical”), completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation (“Catheter”), pursuant to an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, Catheter, Rapid Merger Sub 1, Inc., a newly-created wholly-owned subsidiary of the Company (“First Merger Sub”), and Rapid Merger Sub 2, LLC, a newly-created wholly owned subsidiary of the Company (“Second Merger Sub” and together with First Merger Sub, the “Merger Subs”), entered into on January 9, 2023 evidence_url: https://www.sec.gov/Archives/edgar/data/1716621/000156459023000429/0001564590-23-000429-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.